Malignant glioma

LM Wang, ZK Englander, ML Miller… - Human Brain and Spinal …, 2023 - Springer
This chapter provides a comprehensive overview of malignant gliomas, the most common
primary brain tumor in adults. These tumors are varied in their cellular origin, genetic profile …

Malignant gliomas in adults

PY Wen, S Kesari - New England Journal of Medicine, 2008 - Mass Medical Soc
Malignant gliomas, the most common type of primary brain tumor in adults, are associated
with disproportionate cancer-related morbidity and mortality. Recently, there have been …

An extended mixed‐effects framework for meta‐analysis

F Sera, B Armstrong, M Blangiardo… - Statistics in …, 2019 - Wiley Online Library
Standard methods for meta‐analysis are limited to pooling tasks in which a single effect size
is estimated from a set of independent studies. However, this setting can be too restrictive for …

Malignant astrocytic glioma: genetics, biology, and paths to treatment

FB Furnari, T Fenton, RM Bachoo… - Genes & …, 2007 - genesdev.cshlp.org
Malignant astrocytic gliomas such as glioblastoma are the most common and lethal
intracranial tumors. These cancers exhibit a relentless malignant progression characterized …

Brain tumors

LM DeAngelis - New England journal of medicine, 2001 - Mass Medical Soc
The term “brain tumor” refers to a collection of neoplasms, each with its own biology,
prognosis, and treatment; these tumors are better identified as “intracranial neoplasms,” …

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

M Westphal, DC Hilt, E Bortey, P Delavault… - Neuro …, 2003 - academic.oup.com
A previous placebo-controlled trial has shown that biodegradable 1, 3-bis (2-chloroethyl)-1-
nitrosourea (BCNU) wafers (Gliadel wafers) prolong survival in patients with recurrent …

Long-term survival with glioblastoma multiforme

D Krex, B Klink, C Hartmann, A Von Deimling, T Pietsch… - Brain, 2007 - academic.oup.com
The median survival of glioblastoma patients is∼ 12 months. However, 3–5% of the patients
survives for more than 3 years and are referred to as long-term survivors. The clinical and …

Glioblastoma multiforme: a review of where we have been and where we are going

C Adamson, OO Kanu, AI Mehta, C Di… - Expert opinion on …, 2009 - Taylor & Francis
Malignant gliomas such as glioblastoma multiforme (GBM) present some of the greatest
challenges in the management of cancer patients worldwide, despite notable recent …

Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo—a meta-analysis of individual …

A Louvet, MR Thursz, DJ Kim, J Labreuche… - Gastroenterology, 2018 - Elsevier
Background & Aims We performed a meta-analysis of individual patient data from 11
randomized controlled trials comparing corticosteroids, pentoxifylline, or their combination in …

Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma …

K Maier-Hauff, R Rothe, R Scholz, U Gneveckow… - Journal of neuro …, 2007 - Springer
We aimed to evaluate the feasibility and tolerability of the newly developed thermotherapy
using magnetic nanoparticles on recurrent glioblastoma multiforme. Fourteen patients …